As the 2026 FIFA World Cup kicks off in Mexico this Thursday, we take a look at the tournament’s expected economic impact – both globally and on host countries. But the real winner, it seems, is FIFA, ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

Add Decrypt as your preferred source to see more of our stories on Google. Minnesota lawmakers passed a bill banning AI tools that generate fake nude images. Violators face up to $500,000 per use and ...

The NFL Draft is set for April 23-25, but attention is already beginning to shift to 2027 and its quarterback class. Five signal-callers are emerging as early names to watch, with some analysts ...

Pavan Pidugu, chief digital and information officer at the Department of Transportation, believes that artificial intelligence is not meant to replace human knowledge and skills but to augment them ...

OpenAI has acquired popular tech industry talk show TBPN — Technology Business Programming Network — making this the AI giant’s first acquisition of a media company. The show will report to OpenAI’s ...

Vibe coding lets anyone build custom crypto tools using AI without programming skills. 30 minutes is all it takes to deploy a bot that monitors 500 tokens and sends Telegram alerts. The same workflow ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

According to Claude on X (Twitter), Jon McBee’s Elisa is a block-based visual programming environment for children where snapped blocks trigger Claude agents that generate the underlying production ...